Peptides are short chains of amino acids that send messages to skin cells, telling them to make more collagen or heal faster
This is a once-in-a-generation opportunity to shape not just a drug market, but a healthcare paradigm
Research shows that people taking 96 to 200 mg/day of topiramate lose an average of 5 to 10% of their body weight
Besides Gpx1, Gpx4 displays preference for lipid hydroperoxides ( Figure 3 ), and hence plays a key role in protecting phospholipids, cholesteryl esters and cardiolipin and defense against apoptosis and maintenance of ETC and OXPHOS (Cole-Ezea et al., 2012)
It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists
GLP-1 medications deliver substantially greater weight loss: semaglutide trials showed 1015% body weight reduction over 68 weeks, and tirzepatide (a dual GLP-1/GIP agonist) demonstrated 20%+ reductions in some cohorts